Skip to content

Citius Oncology, Inc. CTOR Balance Sheet Statement

FY'25FY'24FY'23FY'22
$3.92M+3,504,282%$112-99.6%$26.52K-89.4%$250K
$69.22M+601%$9.87M
$27.54M+151%$10.97M+41.8%$7.73M
$100.94M+19.6%$84.37M+76.7%$47.73M+18,492%$256.75K
$13.23M+257%$3.71M+188%$1.29M
$49.49M+51.3%$32.7M+55.4%$21.05M+7,787%$266.86K
$56.08M+46.7%$38.23M+72.2%$22.2M
400M+264%110M+10.0%100M-33.3%150M
-$64.04M-63.0%-$39.28M-117%-$18.13M-179,173%-$10.11K
$44.87M-2.8%$46.14M+80.7%$25.54M-29.6%$36.27M+358,722%
$100.94M+19.6%$84.37M+76.7%$47.73M+18,492%$256.75K

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Citius Oncology, Inc.'s total assets?
Citius Oncology, Inc. (CTOR) holds $100.7M in total assets, up 10.1% year over year.
How much cash does Citius Oncology, Inc. have?
Citius Oncology, Inc. holds $2.6M in cash and equivalents.
Can Citius Oncology, Inc. cover its short-term obligations?
Its current ratio is 0.50 — current liabilities exceed current assets.
Where does Citius Oncology, Inc.'s balance sheet data come from?
Every line is extracted from Citius Oncology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.